×
0 0 0 0 0 0 0 0
Stockreport

Pharmacy-benefit manager stocks pressured as White House calls for lower biotech prices [MarketWatch]

EXPRESS SCRIPTS (ESRX)  More Company Research Source: MarketWatch
Last express scripts earnings: 8/1 04:01 pm Check Earnings Report
PDF Pharmacy-benefit manager stocks pressured as White House calls for lower biotech prices Shares of pharmacy-benefit managers fell Friday after the White House released a paper pushing for lower biotech drug prices. Shares of Express Scripts Holding Co. ESRX, -2.24% declined 2.8%, CVS Health Corp. CVS, -1.64% shares slipped 1.5%, while shares of UnitedHealth Group Inc. UNH, +2.08% with its OptumRx PBM business, swung from a slight loss to be up 0.5%. On Friday, the White House's Coucil of Economic Advisers released a white paper entitled "Reforming Biopharmaceutical Pricing at Home and Abroad" which called for reducing prices of biotech drugs while raising incentives for medical innovation to promote competition. [Read more]

IMPACT SNAPSHOT EVENT TIME: ESRX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ESRX alerts
from News Quantified
Opt-in for
ESRX alerts

from News Quantified
Opt-in for
ESRX alerts

from News Quantified